Invention Grant
US08778402B2 Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
有权
包含皮质类固醇和β-肾上腺素能的干粉制剂用于通过吸入给药
- Patent Title: Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
- Patent Title (中): 包含皮质类固醇和β-肾上腺素能的干粉制剂用于通过吸入给药
-
Application No.: US13748882Application Date: 2013-01-24
-
Publication No.: US08778402B2Publication Date: 2014-07-15
- Inventor: Elisa Monari , Anna Maria Cantarelli , Daniela Cocconi , Irene Pasquali
- Applicant: Chiesi Farmaceutici S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP12152392 20120125
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/16 ; A61K9/50 ; C07J73/00

Abstract:
Dry powder formulations comprising a corticosteroid and a beta2-adrenergic drug in combination are useful for the prevention and/or treatment of inflammatory or obstructive airways diseases.
Public/Granted literature
Information query